Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fuji
Harvard Business School
Queensland Health
Express Scripts
Cerilliant
Medtronic
UBS
Covington

Generated: July 16, 2018

DrugPatentWatch Database Preview

VENLAFAXINE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Venlafaxine Hydrochloride patents expire, and what generic alternatives are available?

Venlafaxine Hydrochloride is a drug marketed by Anchen Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Teva, Torrent Pharms Llc, Valeant Pharms North, Wockhardt, Zydus Pharms Usa Inc, Nostrum Labs Inc, Osmotica Pharm, Sun Pharma Global, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Fosun Pharma, Heritage Pharms Inc, Pliva Hrvatska Doo, Prinston Inc, Sun Pharm Inds Inc, Yaopharma Co Ltd, and Zydus Pharms Usa. and is included in twenty-seven NDAs.

The generic ingredient in VENLAFAXINE HYDROCHLORIDE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Seventy-two suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
Drug patent expirations by year for VENLAFAXINE HYDROCHLORIDE
Pharmacology for VENLAFAXINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for VENLAFAXINE HYDROCHLORIDE
Synonyms for VENLAFAXINE HYDROCHLORIDE
(+-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride
(+/-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride
(+/-)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
(R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride
(RS)-1-(2-Dimethylamino-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride
(RS)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE
1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol hydrochloride
1-(2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-cyclohexanol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, hcl
1-[2-Dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride
1-[2-Dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexanol -HCl
93413-69-5 (Parent)
99300-78-4
A845995
AB0012466
AB2000111
AC-1696
AC1L1Y1S
AK326210
akos 92111
AKOS000280874
AKOS016340594
AN-14687
ANW-42650
API0004582
BC208275
BG0478
Bio-0110
BVF-012
C17H27NO2.HCl
CAS-99300-78-4
CCG-100979
CCG-213270
CHEBI:9944
CHEMBL1201066
CPD000469154
CS-2130
CTK5I0329
Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
d,l-venlafaxine, hydrochloride
D00821
Dobupal
DSSTox_CID_27397
DSSTox_GSID_47397
DSSTox_RID_82318
DTXSID8047397
Efexor
Efexor XL
Effexor
Effexor (TN)
Effexor LP
Effexor XL
Effexor XR
Effexor;Effexor XR;Efexor
FT-0642395
H13V695
HSDB 6699
HY-B0196A
I01-1036
J10231
KB-08072
KM3503
KS-00000WXA
KS-5049
LP00449
LS-57096
MCULE-5156532617
MFCD03658865
MLS001401454
MolPort-003-987-504
NC00229
NCGC00256703-01
NCGC00261134-01
NSC-745751
NSC745751
PF-00345408
PW-4112
QYRYFNHXARDNFZ-UHFFFAOYSA-N
s1441
SAM001246572
SC-23352
SCHEMBL41936
SMR000469154
TL8006063
Tox21_302508
Tox21_500449
TR-030420
Trevilor
Vandral
Venlafaxin HCL
Venlafaxine (hydrochloride)
Venlafaxine EA
Venlafaxine for system suitability, European Pharmacopoeia (EP) Reference Standard
VENLAFAXINE HCl
Venlafaxine Hydorchloride
venlafaxine hydro chloride
Venlafaxine hydrochloride (JAN/USAN)
Venlafaxine hydrochloride [USAN:USP]
Venlafaxine hydrochloride [USAN]
Venlafaxine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Venlafaxine hydrochloride, >=98% (HPLC), powder
Venlafaxine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Venlafaxine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur
Venlafaxine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Venlafaxine XR
Venlafaxinehydrochloride
Wy 45030
Wy-45,030
Wy-45,030 Hcl; 9490-3
Wy-45030

US Patents and Regulatory Information for VENLAFAXINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078554-005 Jan 9, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Yaopharma Co Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 202036-004 May 28, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 091272-002 Aug 18, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090174-002 Apr 14, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for VENLAFAXINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-003 May 20, 2008 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-003 May 20, 2008 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-001 May 20, 2008 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cerilliant
Dow
Teva
US Army
US Department of Justice
Covington
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.